These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 780378)

  • 1. Ripazepam (CI-683): double-blind comparison with placebo in anxious patients.
    Schneyer JJ; Goodman LI; Borgen LA
    J Clin Pharmacol; 1976 Jul; 16(7):377-83. PubMed ID: 780378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SQ 65,396: a non-sedative anxiolytic?
    Sakalis G; Sathananthan G; Collins P; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):861-3. PubMed ID: 4375017
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind evaluation of fenfluramine in anxious somatizing neurotic medical clinic patients.
    Raich WA; Rickels K; Raab E
    Curr Ther Res Clin Exp; 1966 Jan; 8(1):31-3. PubMed ID: 4955145
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of benzoctamine (Ba-30803) in neurotic anxiety.
    Kellner R; Claghorn JL
    J Clin Pharmacol J New Drugs; 1970; 10(5):342-8. PubMed ID: 4917355
    [No Abstract]   [Full Text] [Related]  

  • 5. Methodological considerations in evaluating antianxiety drugs.
    Hollister LE
    J Clin Pharmacol J New Drugs; 1970; 10(1):12-8. PubMed ID: 4903952
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.
    Kingstone E; Villeneuve A; Kossatz I
    Curr Ther Res Clin Exp; 1969 Mar; 11(3):106-14. PubMed ID: 4976238
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study.
    Predescu V; Ciurezu T; Timofte G; Roman I
    Acta Psychiatr Scand; 1973; 49(1):15-27. PubMed ID: 4572167
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
    Sugerman AA; Miksztal MW; Freymuth HW
    J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717
    [No Abstract]   [Full Text] [Related]  

  • 9. SCH 12041. A new antianxiety agent.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):107-10. PubMed ID: 4994212
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of a new minor tranquilizer Y-6047 for the treatment of sleep disturbance on the night before surgery. II. Comparison with diazepam in a double-blind controlled study].
    Hagimori M; Mori Y; Kusumoto H; Aoki A; Tanimoto H
    Masui; 1972 Mar; 21(3):243-50. PubMed ID: 4555737
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):280-5. PubMed ID: 4557536
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled clinical trial of mepiprazole in irritable bowel syndrome.
    Dotevall G; Groll E
    Br Med J; 1974 Oct; 4(5935):16-8. PubMed ID: 4609545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between diazepam, dixyrazine, opripramol and placebo in anxiety states.
    Arfwidsson L; Arn L; Beskow J; Ottosson JO; Persson G
    Acta Psychiatr Scand Suppl; 1971; ():19-32. PubMed ID: 4938880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clozapine in long-term therapy of chronic schizophrenia].
    Gross H; Langner E; Pfolz H
    Arzneimittelforschung; 1974 Jul; 24(7):987-9. PubMed ID: 4408041
    [No Abstract]   [Full Text] [Related]  

  • 15. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of a new antianxiety agent Ba-30803.
    Goldstein BJ; Weiner D
    J Clin Pharmacol J New Drugs; 1970; 10(1):19-23. PubMed ID: 4905244
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative double blind study of doxepine and medazepam in adolescents].
    Moniot M; Misés R
    Ann Med Psychol (Paris); 1971 Mar; 1(3):431-4. PubMed ID: 4934283
    [No Abstract]   [Full Text] [Related]  

  • 19. Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).
    Linden M; Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1988 Jun; 38(6):814-6. PubMed ID: 3178922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazapon (CI-683): a new antianxiety agent.
    Poschel BP; McCarthy DA; Chen G; Ensor CR
    Psychopharmacologia; 1974 Feb; 35(3):257-71. PubMed ID: 4208323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.